|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/07/22 Elbit Systems Ltd. 20-F 12/31/21 159:18M Workiva Inc Wde… FA01/FA |
Document/Exhibit Description Pages Size
1: 20-F Annual or Annual-Transition Report by a Foreign HTML 2.13M
Non-Canadian Issuer
2: EX-2.1 Plan of Acquisition, Reorganization, Arrangement, HTML 66K
Liquidation or Succession
3: EX-4.2.2 Instrument Defining the Rights of Security Holders HTML 121K
4: EX-8 Opinion of Counsel re: Tax Matters HTML 43K
7: EX-13.1 Annual or Quarterly Report to Security Holders HTML 45K
8: EX-13.2 Annual or Quarterly Report to Security Holders HTML 46K
5: EX-12.1 Statement re: the Computation of Ratios HTML 48K
6: EX-12.2 Statement re: the Computation of Ratios HTML 49K
9: EX-15 Letter re: Unaudited Interim Financial Info HTML 45K
15: R1 Cover page HTML 115K
16: R2 Audit Information HTML 49K
17: R3 Consolidated Balance Sheets HTML 191K
18: R4 Consolidated Balance Sheets (Parenthetical) HTML 52K
19: R5 Consolidated Statements Of Income HTML 144K
20: R6 Consolidated Statements Of Comprehensive Income HTML 80K
21: R7 Consolidated Statements Of Comprehensive Income HTML 48K
(Parenthetical)
22: R8 Statements Of Changes In Equity HTML 117K
23: R9 Statements Of Changes In Equity (Parenthetical) HTML 48K
24: R10 Consolidated Statements Of Cash Flows HTML 151K
25: R11 Consolidated Statements Of Cash Flows Supplemental HTML 68K
Schedules
26: R12 Long-Term Loans, Net Of Current Maturities HTML 63K
27: R13 General HTML 89K
28: R14 Significant Accounting Policies HTML 242K
29: R15 Trade And Unbilled Receivables, Net HTML 62K
30: R16 Other Receivables And Prepaid Expenses HTML 54K
31: R17 Inventories HTML 55K
32: R18 Investments In Affiliated Companies, Partnerships HTML 108K
And Other Companies
33: R19 Long-Term Trade And Unbilled Receivables And HTML 51K
Contract Assets
34: R20 Long-Term Bank Deposits And Other Receivables HTML 56K
35: R21 Property, Plant And Equipment, Net HTML 65K
36: R22 Lease Commitments HTML 64K
37: R23 Goodwill And Other Intangible Assets, Net HTML 72K
38: R24 Short-Term Bank Credit And Loans HTML 51K
39: R25 Other Payables And Accrued Expenses HTML 72K
40: R26 Contract Liabilities (Customer Advances) HTML 52K
41: R27 Series B,C And D Notes, Net Of Current Maturities HTML 57K
42: R28 Benefit Plans And Obligations For Termination HTML 188K
Indemnity
43: R29 Taxes On Income HTML 166K
44: R30 Derivative Financial Instruments HTML 92K
45: R31 Other Long-term Liabilities HTML 72K
46: R32 Commitments And Contingent Liabilities HTML 59K
47: R33 Shareholders' Equity HTML 117K
48: R34 Major Customer And Geographic Information HTML 82K
49: R35 Research And Development, Net HTML 53K
50: R36 Financial Expenses, Net HTML 65K
51: R37 Other Income (Expenses), Net HTML 59K
52: R38 Related Parties' Transactions And Balances HTML 61K
53: R39 Valuation And Qualifying Accounts HTML 85K
54: R40 Significant Accounting Policies (Policy) HTML 209K
55: R41 General (Tables) HTML 79K
56: R42 Significant Accounting Policies (Tables) HTML 170K
57: R43 Trade And Unbilled Receivables And Contract HTML 61K
Assets, Net (Tables)
58: R44 Other Receivables And Prepaid Expenses (Tables) HTML 53K
59: R45 Inventories (Tables) HTML 56K
60: R46 Investments In Affiliated Companies, Partnerships HTML 116K
And Other Companies (Tables)
61: R47 Long-Term Trade And Unbilled Receivables And HTML 50K
Contract Assets (Tables)
62: R48 Long-Term Bank Deposits And Other Receivables HTML 56K
(Tables)
63: R49 Property, Plant And Equipment, Net (Tables) HTML 64K
64: R50 Lease Commitments (Tables) HTML 63K
65: R51 Goodwill And Other Intangible Assets, Net (Tables) HTML 81K
66: R52 Short-Term Bank Credit And Loans (Tables) HTML 52K
67: R53 Other Payables And Accrued Expenses (Tables) HTML 62K
68: R54 Contract Liabilities (Customer Advances) (Tables) HTML 51K
69: R55 Long-Term Loans, Net Of Current Maturities HTML 72K
(Tables)
70: R56 Series B,C And D Notes, Net Of Current Maturities HTML 58K
(Tables)
71: R57 Benefit Plans And Obligations For Termination HTML 188K
Indemnity (Tables)
72: R58 Taxes On Income (Tables) HTML 142K
73: R59 Derivative Financial Instruments (Tables) HTML 88K
74: R60 Other Long-term Liabilities (Tables) HTML 54K
75: R61 Shareholders' Equity (Tables) HTML 105K
76: R62 Major Customer And Geographic Information (Tables) HTML 88K
77: R63 Research And Development, Net (Tables) HTML 52K
78: R64 Financial Expenses, Net (Tables) HTML 65K
79: R65 Other Income (Expenses), Net (Tables) HTML 59K
80: R66 Related Parties' Transactions And Balances HTML 60K
(Tables)
81: R67 General - Narrative (Details) HTML 123K
82: R68 General - Acquisitions fair value and expenses HTML 79K
(Details)
83: R69 General - Goodwill and Intangible Asset Table HTML 65K
(Details)
84: R70 General (Total Expenses Related to Acquisition and HTML 55K
Other Non-recurring Expenses) (Details)
85: R71 Significant Accounting Policies (Narrative) HTML 119K
(Details)
86: R72 Significant Accounting Policies (Changes In HTML 80K
Accumulated Other Comprehensive Income By
Components) (Details)
87: R73 Significant Accounting Policies (Schedule Of HTML 60K
Estimated Useful Life Of Assets) (Details)
88: R74 Significant Accounting Policies (Effect of HTML 51K
Cumulative Catch-Up Adjustment) (Details)
89: R75 Significant Accounting Policies (Disaggregation of HTML 67K
Revenues) (Details)
90: R76 Significant Accounting Policies (Schedule Of HTML 52K
Warranty Liability) (Details)
91: R77 Significant Accounting Policies (Schedule Of HTML 80K
Assets And Liabilities Measured At Fair Value On
Recurring Basis) (Details)
92: R78 Trade And Unbilled Receivables And Contract HTML 59K
Assets, Net - Schedule of trade and unbilled
receivables, net (Details)
93: R79 Trade And Unbilled Receivables And Contract HTML 54K
Assets, Net - Schedule of changes in the allowance
for credit losses (Details)
94: R80 Other Receivables And Prepaid Expenses (Details) HTML 56K
95: R81 Inventories (Details) HTML 59K
96: R82 Investments In Affiliated Companies, Partnerships HTML 51K
And Other Companies (Investments In Affiliated
Companies) (Details)
97: R83 Investments In Affiliated Companies, Partnerships HTML 111K
And Other Companies (Investments In Companies
Accounted For Under The Equity Method) (Details)
98: R84 Investments In Affiliated Companies, Partnerships HTML 61K
And Other Companies (Schedule Of Equity In Net
Earnings Of Affiliated Companies) (Details)
99: R85 Investments In Affiliated Companies, Partnerships HTML 99K
And Other Companies (Balance Sheet Information)
(Details)
100: R86 Investments In Affiliated Companies, Partnerships HTML 75K
And Other Companies (Income Statement Information)
(Details)
101: R87 Investments In Affiliated Companies, Partnerships HTML 63K
And Other Companies Investment in affiliated
companies, Partnership and Other Companies
(Investment Under Fair Value Method) (Details)
102: R88 Long-Term Trade And Unbilled Receivables And HTML 51K
Contract Assets (Details)
103: R89 Long-Term Bank Deposits And Other Receivables HTML 59K
(Details)
104: R90 Property, Plant And Equipment, Net (Narrative) HTML 54K
(Details)
105: R91 Property, Plant And Equipment, Net (Schedule Of HTML 71K
Property, Plant And Equipment, Net) (Details)
106: R92 Lease Commitments (Details) HTML 59K
107: R93 Lease Commitments (Schedule of Supplemental HTML 56K
Consolidated Statement of Financial Position
information Related to Leases) (Details)
108: R94 Lease Commitments (Schedule of Maturities of HTML 63K
Operating Lease Liabilities) (Details)
109: R95 Goodwill And Other Intangible Assets, Net HTML 49K
(Narrative) (Details)
110: R96 Goodwill And Other Intangible Assets, Net HTML 61K
(Schedule Of Aggregate Goodwill And Other
Intangible Assets) (Details)
111: R97 Goodwill And Other Intangible Assets, Net HTML 57K
(Estimated Aggregate Amortization Expense)
(Details)
112: R98 Goodwill And Other Intangible Assets, Net HTML 51K
(Schedule Of Goodwill) (Details)
113: R99 Short-Term Bank Credit And Loans (Details) HTML 62K
114: R100 Other Payables And Accrued Expenses (Details) HTML 69K
115: R101 Contract Liabilities (Customer Advances) (Details) HTML 54K
116: R102 Long-Term Loans, Net Of Current Maturities HTML 70K
(Summary Of Long-Term Loans, Net Of Current
Maturities) (Details)
117: R103 Long-Term Loans, Net Of Current Maturities HTML 61K
(Summary Of Maturities Of Long-Term Loans)
(Details)
118: R104 Series B,C And D Notes, Net Of Current Maturities HTML 55K
(Schedule Of Series A Notes, Net Of Current
Maturities) (Details)
119: R105 Series B,C And D Notes, Net Of Current Maturities HTML 85K
(Narrative) (Details)
120: R106 Series B,C And D Notes, Net Of Current Maturities HTML 64K
(Schedule Of Future Principal Payments For The
Series A Notes) (Details)
121: R107 Benefit Plans And Obligations For Termination HTML 87K
Indemnity (Narrative) (Details)
122: R108 Benefit Plans And Obligations For Termination HTML 113K
Indemnity (Plans' Funded Status And Amounts
Recognized In The Consolidated Financial
Statements) (Details)
123: R109 Benefit Plans And Obligations For Termination HTML 69K
Indemnity (Components Of The Plans Net Periodic
Pension Cost) (Details)
124: R110 Benefit Plans And Obligations For Termination HTML 58K
Indemnity (Weighted Average Assumptions) (Details)
125: R111 Benefit Plans And Obligations For Termination HTML 52K
Indemnity (Asset Allocation By Category) (Details)
126: R112 Benefit Plans And Obligations For Termination HTML 50K
Indemnity (Target Asset Allocation For The Plan)
(Details)
127: R113 Benefit Plans And Obligations For Termination HTML 82K
Indemnity (Fair Value Of The Asset Values By
Category) (Details)
128: R114 Benefit Plans And Obligations For Termination HTML 53K
Indemnity (Effect Of A 1% Change In The Health
Care Cost Trend Rate) (Details)
129: R115 Taxes On Income (Narrative) (Details) HTML 81K
130: R116 Taxes On Income (Schedule Of Income Before Taxes HTML 52K
On Income) (Details)
131: R117 Taxes On Income (Schedule Of Taxes On Income) HTML 76K
(Details)
132: R118 Taxes On Income (Schedule Of Uncertain Tax HTML 62K
Positions) (Details)
133: R119 Taxes On Income (Schedule Of Deferred Income HTML 75K
Taxes) (Details)
134: R120 Taxes On Income (Schedule Of Effective Income Tax HTML 77K
Rate Reconciliation) (Details)
135: R121 Derivative Financial Instruments (Narrative) HTML 48K
(Details)
136: R122 Derivative Financial Instruments (Schedule Of HTML 61K
Derivative Instruments In Statement Of Financial
Position, Fair Value) (Details)
137: R123 Derivative Financial Instruments (Effect Of HTML 51K
Derivative Instruments On Cash Flow Hedging And
Relationship Between Income And Other
Comprehensive Income) (Details)
138: R124 Derivative Financial Instruments (Notional Amounts HTML 62K
Of Outstanding Foreign Exchange Forward Contracts)
(Details)
139: R125 Other Long-term Liabilities (Details) HTML 56K
140: R126 Commitments And Contingent Liabilities (Narrative) HTML 59K
(Details)
141: R127 Shareholders' Equity (Narrative) (Details) HTML 100K
142: R128 Shareholders' Equity (Summary Of Share Option HTML 66K
Activity Under The Stock Option Plan) (Details)
143: R129 Shareholders' Equity (Summary Of Options HTML 60K
Outstanding Separated Into Ranges Of Exercise
Prices) (Details)
144: R130 Shareholders' Equity (Compensation Expenses) HTML 66K
(Details)
145: R131 Shareholders' Equity (Computation Of Basic And HTML 75K
Diluted Net Earnings Per Share) (Details)
146: R132 Major Customer And Geographic Information HTML 61K
(Schedule Of Revenue By Geographic Areas)
(Details)
147: R133 Major Customer And Geographic Information HTML 57K
(Schedule Of Revenues By Areas Of Operations)
(Details)
148: R134 Major Customer And Geographic Information HTML 53K
(Schedule Of Major Customer Data) (Details)
149: R135 Major Customer And Geographic Information HTML 52K
(Schedule Of Long-Lived Assets By Geographic
Areas) (Details)
150: R136 Research And Development, Net (Details) HTML 51K
151: R137 Financial Expenses, Net (Details) HTML 66K
152: R138 Other Income (Expenses), Net (Details) HTML 57K
153: R139 Related Parties' Transactions And Balances HTML 69K
(Details)
154: R140 Valuation And Qualifying Accounts (Details) HTML 82K
157: XML IDEA XML File -- Filing Summary XML 320K
155: XML XBRL Instance -- eslt-20211231_htm XML 4.50M
156: EXCEL IDEA Workbook of Financial Reports XLSX 215K
11: EX-101.CAL XBRL Calculations -- eslt-20211231_cal XML 403K
12: EX-101.DEF XBRL Definitions -- eslt-20211231_def XML 1.32M
13: EX-101.LAB XBRL Labels -- eslt-20211231_lab XML 3.06M
14: EX-101.PRE XBRL Presentations -- eslt-20211231_pre XML 1.91M
10: EX-101.SCH XBRL Schema -- eslt-20211231 XSD 385K
158: JSON XBRL Instance as JSON Data -- MetaLinks 726± 1.08M
159: ZIP XBRL Zipped Folder -- 0001628280-22-008651-xbrl Zip 853K
| Document |
“Administrator” | The Board, or a committee to which the Board delegates power to act on its behalf with respect to the Plan. Subject to the Articles of Association of the Company, as may be amended from time to time, the Administrator, if it is a committee, will consist of such number of members (but not less than two (2)) as may be determined by the Board and subject to the requirements of Applicable Law; | ||||
"Affiliate" | Each Subsidiary and any company in which the Company or a Subsidiary owns, directly or indirectly, ownership rights; | ||||
"Applicable Law" | The legal requirements applicable to the administration of equity incentive plans which include the Plan, any applicable laws, rules and regulations applicable to the Options granted under the Plan, as such laws, rules, regulations and requirements shall be in place from time to time, including any TASE rules or regulations; | ||||
“Approved Option” | An Option granted under Section 102(b)(2) of the Ordinance, in accordance with the "capital gain tax route", and other rights granted or issued with respect to such Option; | ||||
“Award Agreement” | A written agreement between the Company and a Participant or a notice provided by the
Company to a Participant, setting forth the terms and conditions under which Options are granted to a Participant, in a form to be determined by the Company; | ||||
"Benefit" | The amount determined in accordance with Section 10; | ||||
“Cause”
| Irrespective of any definition to the contrary in any other document held by a Participant and unless otherwise determined in the Participant’s respective Award Agreement, the term Cause, when used herein shall include any of the following: (a) an act or omission of, or by, the Participant, that is detrimental to the Company and/or an Affiliate, including, but not limited to: dishonesty toward the Company/Affiliate, insubordination, substantial malfeasance or nonfeasance of duty, unauthorized disclosure of confidential or proprietary information and any other conduct substantially prejudicial to the business of the
Company/Affiliate; (b) any substantial breach by the Participant of (i) his or her employment agreement or engagement arrangements, or (ii) any other obligations toward the Company/Affiliate; (c) circumstances justifying the revocation and/or reduction of a Participant’s entitlement to severance pay under Applicable Law, including where relevant, pursuant to Sections 16 or 17 of the Severance Pay Law, 1963; or (d) any other reason which is defined as Cause in the Participant’s personal employment contract or engagement arrangements or is defined as such in the Company's or
Affiliate's internal procedures; For the avoidance of doubt it is clarified that the determination as to whether a Participant is being terminated for Cause shall be made in good faith by the Administrator and shall be final and binding on the Participant; | ||||
"Controlling Shareholder" | A controlling shareholder of the Company as defined in section 32(9) of the Ordinance, as amended from time to time; | ||||
"Eligible Employee" | Any person, who has signed an employment agreement and has commenced employment with the Company or any Subsidiary, or anyone who is on the payroll of such corporation and specifically excluding anyone who may under Applicable Law be deemed an employee of the Company or a Subsidiary if an employment agreement was not signed and he or she is not on the payroll of such company; | ||||
“Exercise Price” | The price determined by the Administrator in accordance with Section 9 below, which shall be used for the purpose of calculating the Benefit and determining the number of Underlying Shares to be issued to the Participant as the result of the exercise of an Option; | ||||
| "Exercise Notice" | A notice in the form as shall be dictated by the Company, to be provided by a Participant for the purpose of exercising an Option in accordance with Section 10; | ||||
“Expiry Date” | With respect to an Option, and unless otherwise determined in the Award Agreement - 51 months from the Grant Date of the Option, unless terminated earlier due to such Option being fully exercised, or in accordance with Sections 14 and 16; | ||||
“Fair
Market Value” | As of any date, the value of a Share determined as follows: (i) if the Shares are listed on the TASE, the Fair Market Value will be the closing price for one Share as quoted on the TASE for the market trading day prior to time of determination; or (ii) in the absence of the above, the Fair Market Value of a Share shall be as determined in good faith by the Administrator. For the avoidance of doubt, and where applicable, the above definition of Fair Market Value shall not apply for the purpose of determining the tax liability pursuant to Section 102(b)(3) of the Ordinance; | ||||
"Grant Date" | The later of (i) the date on which the grant of the Options to a Participant was approved by the Administrator; (ii) the first trading day after a period of 30 days from the filing of the Plan for approval with the ITA has lapsed; unless otherwise determined by the Board or required under Applicable Law; | ||||
"Holding Period" | The holding period provided under Section 102 in respect of the "capital gain tax route" or under a tax ruling by the Israeli Tax Authority; | ||||
"Israeli Employee" | An Eligible Employee of the Company or
of an Israeli resident Subsidiary, who is an Israeli tax resident and who is not a Controlling Shareholder at the time of grant, or as a consequence of the grant, as stated in Section 102; | ||||
"ITA" | The Israeli Tax Authority; | ||||
“Ordinance” | The Israeli Income Tax Ordinance [New Version], 1961, as amended from time to time; | ||||
“Option” | An option to purchase one Share, granted to a Participant, subject to the provisions of this Plan and the applicable Award Agreement; | ||||
“Participant” | An Eligible Employee to whom an Option under the Plan was granted; | ||||
| “M&A Transaction” | Any of the following (yet excluding any Structural Change or Spin-off Transaction): (a) a sale of all or substantially all the assets of the Company and its Subsidiaries taken
as a whole, or the sale or disposition (whether by merger or otherwise) of one or more Subsidiary of the Company if substantially all of the assets of the Company and its Subsidiaries taken as a whole are held by such Subsidiary or Subsidiaries; (b) a merger (including a reverse triangular merger), consolidation, amalgamation or like transaction of the Company with or into another entity or a scheme of arrangement for the purpose of effecting such; or (c)
a sale (including an exchange) of all or substantially all of the share capital of the Company to a third party unrelated to the then current shareholders of the Company, whether by a single transaction or a series of related transactions or within the scope of the same acquisition agreement; or (d) Any other transaction or set of circumstances that is determined by the Board, in its discretion, to be a transaction having a similar or comparable effect. The Board may, at its discretion and subject to a specific Board resolution to that effect, expand the definition so as to include also any purchase by a current shareholder of the
Company (whether directly or indirectly) of all of the share capital of the Company not owned by such shareholder or its affiliates prior to such acquisition: | ||||
| "NIS" | New Israeli Shekels; | ||||
“Non-Approved 102 Option” | An Option which is governed by Section 102(c) of the Ordinance; | ||||
“Section 102” | Section 102 of the Ordinance and the Israeli Income Tax Rules (Tax Relief in Issuance of Shares to Employees) 2003, as amended from time to time; | ||||
| “Share” | An ordinary share of the Company, nominal value 1.00 NIS; | ||||
| "Spin off Transaction" | Any transaction in which assets of the Company are transferred or sold to a company or corporate entity in which the shareholders of the Company hold the same respective ownership stakes they are then holding in the Company; | ||||
| "Structural Change" | Any re-domestication of the Company, share flip, creation of a holding company for the Company which will hold substantially all of the shares of the Company or any other transaction involving the Company in which the shares of the Company outstanding immediately prior to such transaction continue to represent, or are converted into or exchanged for shares that represent, immediately following such transaction, at least a majority, by voting power, of the share capital of the surviving, acquiring or resulting corporation; | ||||
"Subsidiary" | Any corporation wholly owned, directly or indirectly by the Company; | ||||
| “Successor Company” | Any entity with, or into, which the Company is merged or consolidated, or to which certain operations or certain assets of the Company are transferred, or which purchased substantially all the Company’s assets or shares, including any parent of such entity; | ||||
| "TASE" | The Tel Aviv Stock Exchange
Ltd; | ||||
| “Tax” | Any applicable tax and other compulsory payments such as social security and health tax contributions (including interest and/or fines of any type and/or linkage differentials) required to be paid under Applicable Law in relation to the Options, the Underlying Shares or the rights deriving from any of them; | ||||
“Termination” | The termination of employment relations, or the occurrence of any termination event as set forth in the Participant's Award Agreement; For the purpose of this plan the following shall not be considered
as Termination: – paid vacation, sick leave, paid maternity leave, infant care leave, medical emergency leave, military reserve duty, or any other leave of absence authorized in writing by the Administrator; Termination shall not include any transfer of a Participant between the Company and any Affiliate or between Affiliates and with respect to Options granted to U.S. Taxpayers references to Termination shall be construed to require a “separation from service” as such term is defined in Section 409A of the U.S. Internal Revenue Code of 1986; | ||||
| “Termination Date” | The first day on which there are no longer employment relations between the Participant and the Company or an Affiliate, for any reason whatsoever; however for the purpose of Termination for Cause, the Termination Date is the date on which a notice regarding such Termination was sent by the Company or an Affiliate, to the Participant; | ||||
| "Transfer" | With respect of any Option or Underlying Share – the sale, assignment, transfer, pledge, mortgage or other disposition thereof or the grant of any right to a third party thereto; | ||||
“Trustee” | The trustee appointed by the Company in accordance with Section 102; | ||||
| "Underlying Shares" | Shares issued or issuable upon exercise of Options in accordance with the Plan; | ||||
| “U.S. Taxpayer” | Any Participant who is a citizen or permanent resident of the United States for purposes of the U.S. Internal Revenue Code of 1986 or a Participant for whom the compensation under this Plan would otherwise be subject to income tax under the U.S. Internal Revenue Code of 1986; | ||||
| “Vesting Date” | The date on which an Option becomes vested, as determined in accordance with this Plan and set forth in the Award Agreement. | ||||
| This ‘20-F’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 4/7/22 | 6-K | ||
| 1/16/22 | ||||
| For Period end: | 12/31/21 | 6-K, SD | ||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/28/24 Elbit Systems Ltd. 20-F 12/31/23 157:17M Workiva Inc Wde… FA01/FA 5/02/23 SEC UPLOAD¶ 5/31/23 2:39K Elbit Systems Ltd. 5/01/23 Elbit Systems Ltd. 20-F 12/31/22 158:19M Workiva Inc Wde… FA01/FA 3/23/23 SEC UPLOAD¶ 5/31/23 2:43K Elbit Systems Ltd. 2/14/23 SEC UPLOAD¶ 5/31/23 2:51K Elbit Systems Ltd. 12/13/22 SEC UPLOAD¶ 5/31/23 2:42K Elbit Systems Ltd. 11/07/22 SEC UPLOAD¶ 5/31/23 2:46K Elbit Systems Ltd. |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/24/21 Elbit Systems Ltd. 20-F 12/31/20 161:19M Workiva Inc Wde… FA01/FA 3/03/21 Elbit Systems Ltd. 6-K 3/03/21 3:1.1M Workiva Inc Wde… FA01/FA 3/25/20 Elbit Systems Ltd. 20-F 12/31/19 164:21M Workiva Inc Wde… FA01/FA 3/19/19 Elbit Systems Ltd. 20-F 12/31/18 162:21M Workiva Inc Wde… FA01/FA 3/01/18 Elbit Systems Ltd. 6-K 2/28/18 3:991K Workiva Inc Wde… FA01/FA 3/22/16 Elbit Systems Ltd. 20-F 12/31/15 153:17M Workiva Inc Wde… FA01/FA |